Synuclein-related assays (Oligo-SNCA, SNCA, pSNCA-129) appear to capture synuclein pathology related to PD, whereas NEFL seems to be a better marker for FTD, and p-tau217 for AD. This evidence concerns the gene SNCA and Parkinson disease.